ACTIVE

apotheek Schyvens

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result28,9 k €-5,0 %over 1 year
Gross margin211 k €+15,1 %over 1 year
Equity382,6 k €-0,9 %over 1 year
Workforce2,3 ETP+53,3 %over 1 year

Identity

Source · BCE/KBO

apotheek Schyvens is a Private limited company incorporated in 1968. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Vorselaar. It employs on average 2,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0404.191.575
Incorporation
01/01/1968
Legal form
Private limited company
Registered office
Kerkstraat 18
2290 Vorselaar · FlandreSee on map
Contributed capital
222 000,00 €
Latest accounts
31/12/2025
Average workforce
2,3 ETP
Joint committees (2)
  • 100
  • 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 14 financial years

20252024202320222021
Income statement
Gross margin211 k €183,3 k €207,6 k €194,8 k €232,3 k €
EBITDA96,2 k €93 k €124,8 k €119,1 k €161 k €
Operating result59,2 k €58,9 k €90,1 k €85,8 k €138,9 k €
Net result28,9 k €30,5 k €54,7 k €50,5 k €90,8 k €
Balance sheet
Equity382,6 k €386,2 k €386,2 k €386,2 k €386,2 k €
Total assets1,2 M €1,1 M €1,2 M €1,2 M €1,2 M €
Cash181,5 k €199,5 k €282,7 k €318 k €335,6 k €
Debts789,2 k €708,1 k €797,5 k €843,8 k €813,3 k €
Other
Workforce2,3 ETP1,5 ETP1,3 ETP1,2 ETP1,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 6 ended

Active mandates

MJ Pharma

Bestuurder · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Active
VITAPO

Bestuurder · 0638.890.597

Represented by Jan Ceulemans

Active

Ended mandates

MJ Pharma

Director · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Ended
MJ Pharma BV

Bestuurder · since 14 octobre 2020

Represented by Julie Schyvens

Ended
HELENE GODIN

Manager

Ended
VITAPO

Director · 0638.890.597

Represented by Caroline Verlinden

Ended

Other companies at this address

Kerkstraat 18 2290 Vorselaar
CompanyCBE no.
MJ Pharma● Active
0755.612.578
VITAPO● Active
0638.890.597

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date16/07/202631/07/202530/07/202430/06/202320/07/202222/07/2021
General meeting15/06/202616/06/202530/06/202419/06/202320/06/202221/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202515/06/202616/07/2026DutchPDF
Abridged model31/12/202416/06/202531/07/2025DutchPDF
Abridged model31/12/202330/06/202430/07/2024DutchPDF
Abridged model31/12/202219/06/202330/06/2023DutchPDF
Abridged model31/12/202120/06/202220/07/2022DutchPDF
Abridged model31/12/202021/06/202122/07/2021DutchPDF
Abridged model31/12/201915/06/202024/07/2020DutchPDF
Abridged model31/12/201817/06/201902/08/2019DutchPDF
Abridged model31/12/201718/06/201820/07/2018DutchPDF
Abridged model31/12/201619/06/201731/08/2017DutchPDF
Abridged model31/12/201520/06/201627/08/2016DutchPDF
Abridged model31/12/201415/06/201514/07/2015DutchPDF
Abridged model31/12/201316/06/201427/06/2014DutchPDF
Abridged model31/12/201215/06/201328/06/2013DutchPDF
Abridged model31/12/201115/06/201229/06/2012DutchPDF
Abridged model31/12/201015/06/201129/06/2011DutchPDF
Abridged model31/12/200915/06/201002/07/2010DutchPDF
Abridged model31/12/200815/06/200922/06/2009DutchPDF
Abridged model31/12/200716/06/200816/07/2008DutchPDF
Abridged model31/12/200629/06/200713/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 6 ended

Active mandates

MJ Pharma

Bestuurder · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Active
VITAPO

Bestuurder · 0638.890.597

Represented by Jan Ceulemans

Active

Ended mandates

MJ Pharma

Director · since 14 octobre 2020 · 0755.612.578

Represented by Julie Schyvens

Ended
MJ Pharma BV

Bestuurder · since 14 octobre 2020

Represented by Julie Schyvens

Ended
HELENE GODIN

Manager

Ended
VITAPO

Director · 0638.890.597

Represented by Caroline Verlinden

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates08/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates23/10/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates30/12/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/10/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares27/03/2014
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other22/03/2004
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202528,9 k €↓
  2. 2024
    Annual accounts 202430,5 k €↓
  3. 2023
    Annual accounts 202354,7 k €↑
  4. 2022
    Annual accounts 202250,5 k €↓
  5. 2021
    Annual accounts 202190,8 k €↑
  6. 2014
    Annual accounts 201477,6 k €↑
  7. 2013
    Annual accounts 201357,2 k €↓
  8. 2012
    Annual accounts 201262,1 k €↑
  9. 2011
    Annual accounts 201150,3 k €↑
  10. 2010
    Annual accounts 201046,3 k €↓
  11. 2009
    Annual accounts 200969,2 k €↑
  12. 2008
    Annual accounts 200866,8 k €↑
  13. 2007
    Annual accounts 200749,2 k €↓
  14. 2006
    Annual accounts 200658,2 k €
  15. 01/01/1968
    IncorporationPrivate limited company